tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Henry Schein Board Advances CEO Succession and Transition

Story Highlights
  • Henry Schein is a leading global health care solutions provider to dental and medical practitioners with a vast product and service portfolio.
  • Henry Schein expects to name a new CEO by mid-January 2026, with Stanley Bergman extending his tenure to ensure a stable leadership transition.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Henry Schein Board Advances CEO Succession and Transition

Claim 70% Off TipRanks This Holiday Season

Henry Schein ( (HSIC) ) has provided an update.

On December 23, 2025, Henry Schein announced that its board expects to appoint a new chief executive officer by mid-January 2026, marking the final phase of a succession process closely watched by investors given the company’s size and role in global health care distribution. Until the successor takes over, long-serving CEO and chairman Stanley M. Bergman will remain in his roles under an extended employment agreement, a move designed to ensure leadership continuity and a smooth transition while the board completes its evaluation of a strong slate of candidates, signaling stability in the company’s strategic direction for customers, employees, and other stakeholders.

The most recent analyst rating on (HSIC) stock is a Buy with a $86.00 price target. To see the full list of analyst forecasts on Henry Schein stock, see the HSIC Stock Forecast page.

Spark’s Take on HSIC Stock

According to Spark, TipRanks’ AI Analyst, HSIC is a Outperform.

Henry Schein’s overall stock score reflects strong earnings call insights and positive technical indicators, offset by moderate financial performance and valuation concerns. The company’s strategic initiatives and share repurchase program bolster confidence, while increased leverage and cash conversion efficiency remain areas to watch.

To see Spark’s full report on HSIC stock, click here.

More about Henry Schein

Henry Schein, Inc. is the world’s largest provider of health care solutions to office-based dental and medical practitioners, offering more than 300 business, clinical, technology, and supply chain solutions to over 1 million customers worldwide. The Fortune 500 company operates a centralized, automated distribution network carrying more than 300,000 branded and corporate-brand products, employs roughly 25,000 people, has operations or affiliates in 33 countries and territories, and generated $12.7 billion in sales in 2024, with compound annual growth of about 11.2 percent since its 1995 IPO.

Average Trading Volume: 1,449,599

Technical Sentiment Signal: Strong Buy

Current Market Cap: $9.11B

Find detailed analytics on HSIC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1